Literature DB >> 23424002

Reduced microglial CX3CR1 expression delays neurofibromatosis-1 glioma formation.

Winnie W Pong1, Samantha B Higer, Scott M Gianino, Ryan J Emnett, David H Gutmann.   

Abstract

Although traditional models of carcinogenesis have largely focused on neoplastic cells, converging data have revealed the importance of non-neoplastic stromal cells in influencing tumor growth and progression. Leveraging a genetically engineered mouse model of neurofibromatosis type 1 (NF1)-associated optic glioma, we now demonstrate that stromal microglia express the CX3CR1 chemokine receptor, such that reduced CX3CR1 expression decreases optic nerve microglia. Moreover, genetic reduction of Cx3cr1 expression in Nf1 optic glioma mice delays optic glioma formation. Coupled with previous findings demonstrating that microglia maintain optic glioma growth, these new findings provide a strong preclinical rationale for the development of future stroma-directed glioma therapies in children.
Copyright © 2013 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23424002      PMCID: PMC3608848          DOI: 10.1002/ana.23813

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  20 in total

1.  Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion.

Authors:  S Jung; J Aliberti; P Graemmel; M J Sunshine; G W Kreutzberg; A Sher; D R Littman
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

Review 2.  Accessories to the crime: functions of cells recruited to the tumor microenvironment.

Authors:  Douglas Hanahan; Lisa M Coussens
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

Review 3.  Microglia function in brain tumors.

Authors:  Jyoti J Watters; Jill M Schartner; Behnam Badie
Journal:  J Neurosci Res       Date:  2005-08-01       Impact factor: 4.164

4.  Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth.

Authors:  Girish C Daginakatte; David H Gutmann
Journal:  Hum Mol Genet       Date:  2007-03-30       Impact factor: 6.150

Review 5.  Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations.

Authors:  Robert Listernick; Rosalie E Ferner; Grant T Liu; David H Gutmann
Journal:  Ann Neurol       Date:  2007-03       Impact factor: 10.422

6.  Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans.

Authors:  David H McDermott; Alan M Fong; Qiong Yang; Joan M Sechler; L Adrienne Cupples; Maya N Merrell; Peter W F Wilson; Ralph B D'Agostino; Christopher J O'Donnell; Dhavalkumar D Patel; Philip M Murphy
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

7.  IL-6 is required for glioma development in a mouse model.

Authors:  Jakob Weissenberger; Sébastien Loeffler; Andreas Kappeler; Manfred Kopf; Anton Lukes; Tatiana A Afanasieva; Adriano Aguzzi; Joachim Weis
Journal:  Oncogene       Date:  2004-04-22       Impact factor: 9.867

8.  CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration.

Authors:  Christophe Combadière; Charles Feumi; William Raoul; Nicole Keller; Mathieu Rodéro; Adeline Pézard; Sophie Lavalette; Marianne Houssier; Laurent Jonet; Emilie Picard; Patrice Debré; Mirna Sirinyan; Philippe Deterre; Tania Ferroukhi; Salomon-Yves Cohen; Dominique Chauvaud; Jean-Claude Jeanny; Sylvain Chemtob; Francine Behar-Cohen; Florian Sennlaub
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

9.  Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity.

Authors:  M Livia Bajenaru; M Rosario Hernandez; Arie Perry; Yuan Zhu; Luis F Parada; Joel R Garbow; David H Gutmann
Journal:  Cancer Res       Date:  2003-12-15       Impact factor: 12.701

10.  Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas.

Authors:  Michael Platten; Alexandra Kretz; Ulrike Naumann; Steffen Aulwurm; Kensuke Egashira; Stefan Isenmann; Michael Weller
Journal:  Ann Neurol       Date:  2003-09       Impact factor: 10.422

View more
  59 in total

Review 1.  An update on the central nervous system manifestations of neurofibromatosis type 1.

Authors:  J Stephen Nix; Jaishri Blakeley; Fausto J Rodriguez
Journal:  Acta Neuropathol       Date:  2019-04-08       Impact factor: 17.088

Review 2.  A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.

Authors:  Nancy Ratner; Shyra J Miller
Journal:  Nat Rev Cancer       Date:  2015-04-16       Impact factor: 60.716

3.  NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1.

Authors:  Joseph A Toonen; Corina Anastasaki; Laura J Smithson; Scott M Gianino; Kairong Li; Robert A Kesterson; David H Gutmann
Journal:  Hum Mol Genet       Date:  2016-02-16       Impact factor: 6.150

4.  Microglia in the tumor microenvironment: taking their TOLL on glioma biology.

Authors:  David H Gutmann
Journal:  Neuro Oncol       Date:  2014-12-18       Impact factor: 12.300

5.  Inflaming glioma growth.

Authors:  Marlene Arzt; Michelle Monje
Journal:  Neuro Oncol       Date:  2019-10-09       Impact factor: 12.300

6.  Loss of the tyrosine phosphatase PTPRD leads to aberrant STAT3 activation and promotes gliomagenesis.

Authors:  Berenice Ortiz; Armida W M Fabius; Wei H Wu; Alicia Pedraza; Cameron W Brennan; Nikolaus Schultz; Kenneth L Pitter; Jacqueline F Bromberg; Jason T Huse; Eric C Holland; Timothy A Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-19       Impact factor: 11.205

7.  RNA-sequencing reveals oligodendrocyte and neuronal transcripts in microglia relevant to central nervous system disease.

Authors:  Anne C Solga; Winnie W Pong; Jason Walker; Todd Wylie; Vincent Magrini; Anthony J Apicelli; Malachi Griffith; Obi L Griffith; Shinichi Kohsaka; Gregory F Wu; David L Brody; Elaine R Mardis; David H Gutmann
Journal:  Glia       Date:  2014-09-24       Impact factor: 7.452

8.  Genetic and genomic alterations differentially dictate low-grade glioma growth through cancer stem cell-specific chemokine recruitment of T cells and microglia.

Authors:  Xiaofan Guo; Yuan Pan; David H Gutmann
Journal:  Neuro Oncol       Date:  2019-10-09       Impact factor: 12.300

9.  Human pontine glioma cells can induce murine tumors.

Authors:  Viola Caretti; A Charlotte P Sewing; Tonny Lagerweij; Pepijn Schellen; Marianna Bugiani; Marc H A Jansen; Dannis G van Vuurden; Anna C Navis; Ilona Horsman; W Peter Vandertop; David P Noske; Pieter Wesseling; Gertjan J L Kaspers; Javad Nazarian; Hannes Vogel; Esther Hulleman; Michelle Monje; Thomas Wurdinger
Journal:  Acta Neuropathol       Date:  2014-04-29       Impact factor: 17.088

Review 10.  Microglia-Mediated Inflammation and Neurodegenerative Disease.

Authors:  Ling Xu; Dan He; Ying Bai
Journal:  Mol Neurobiol       Date:  2015-12-10       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.